Cointime

Biomendex

company

About

The first adaptive bone graft substitute in the world.

  • 1 - 10

Highlights

Total Funding Amount
€2.25M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
€2.25M
Industries
Biotechnology,Health Care,Manufacturing
Founded date
Jan 1, 2018
Number Of Employee
1 - 10
Operating Status
Active

Biomendex develops and manufactures adaptable synthetic bone substitute materials for bone regeneration. Their invention, Adaptos®, is the first bioactive bone graft substitute that surgeons can cut, shape or squeeze into place. It is the only bone graft substitute that mimics bone by being resilient and bioactive. Adaptos® bone graft substitutes are being developed for clinical and veterinary use.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€2.25M
Biomendex has raised a total of €2.25M in funding over 2 rounds. Their latest funding was raised on Sep 20, 2019 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 20, 2019 Grant €2.25M 1 European Innovation Council — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Biomendex is funded by 1 investors. European Innovation Council are the most recent investors.
Investor Name Lead Investor Funding Round
European Innovation Council Yes Grant
Cointime
เนื้อหา
บริษัท